EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sex-Specific Diagnostic Inequality in Fabry Disease: Lessons Learned from Analysis of Newborn Screening and Cascade Testing in Tennessee from 2017 to 2024

Yutaka Furuta, Neena S Agrawal, Natalie N Owen, Lisa A Bastarache, Cathy Shyr, Hanabi U Geiger, Shayna Jackson, Chelsea J Lauderdale, Camille R Carter, Karee A Morgan, Rizwan Hamid, John A Phillips Iii und 1 weitere

Public Health Genomics · 2026

DOI: 10.1159/000551086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Genomics, 2026. Verfasst von Yutaka Furuta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA, yutakaf…. Hauptthemen laut MEDLINE: Fabry Disease, Neonatal Screening. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Fabry disease (FD) is an X-linked lysosomal storage disease caused by alpha-galactosidase A (aGAL) deficiency. Newborn screening (NBS) programs for FD have been implemented in several U.S. states; however, its effectiveness in identifying affected females remains uncertain. We hypothesized that sex-specific inequality of NBS-based detection of FD results in different diagnostic pathways for males and females with FD.

Methods

We compared diagnostic approaches for males and females with FD using Tennessee NBS results and Vanderbilt Lysosomal Storage Disorders Database (VLSDD). Sex-specific detection differences were assessed using Fisher’s exact test (α=0.05).

Results

Tennessee NBS identified 25 males but no females with FD from 2017-2024. In VLSDD, among 81 individuals with FD, sex distribution was nearly equal (42 males, 39 females). Among males, 26/42 (62%) were diagnosed via NBS, 7/42 (17%) through known family history, and 9/42 (21%) based on clinical symptoms. All 16 males diagnosed through non-NBS were born before its implementation. In contrast, none of the 39 females were diagnosed through NBS (p-value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseNeonatal ScreeningHumansFemaleTennesseeInfant, NewbornMaleSex Factors

Stichwörter der Autor:innen

Cascade testingFabry diseaseNewborn screeningTennessee

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA, yutakafuruta8@gmail.com.
  • Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Medical Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Förderung

  • NICHD NIH HHS

Zitieren

APA

Furuta, Y., Agrawal, N. S., Owen, N. N., Bastarache, L. A., Shyr, C., Geiger, H. U., Jackson, S., Lauderdale, C. J., Carter, C. R., Morgan, K. A., Hamid, R., Phillips Iii, J. A., & Tinker, R. J. (2026). Sex-Specific Diagnostic Inequality in Fabry Disease: Lessons Learned from Analysis of Newborn Screening and Cascade Testing in Tennessee from 2017 to 2024. Public Health Genomics. https://doi.org/10.1159/000551086

Vancouver

Furuta Y, Agrawal NS, Owen NN, Bastarache LA, Shyr C, Geiger HU, et al. Sex-Specific Diagnostic Inequality in Fabry Disease: Lessons Learned from Analysis of Newborn Screening and Cascade Testing in Tennessee from 2017 to 2024. Public Health Genomics. 2026. doi:10.1159/000551086

BibTeX
@article{Furuta2026,
  author = {Furuta, Yutaka and Agrawal, Neena S and Owen, Natalie N and Bastarache, Lisa A and Shyr, Cathy and Geiger, Hanabi U and Jackson, Shayna and Lauderdale, Chelsea J and Carter, Camille R and Morgan, Karee A and Hamid, Rizwan and Phillips Iii, John A and Tinker, Rory J},
  title = {Sex-Specific Diagnostic Inequality in Fabry Disease: Lessons Learned from Analysis of Newborn Screening and Cascade Testing in Tennessee from 2017 to 2024},
  journal = {Public Health Genomics},
  year = {2026},
  doi = {10.1159/000551086}
}
Kostenlos starten →